Finance

Beta
Lists
4569:TYO
Kyorin Pharmaceutical Co Ltd
Â¥1,266.00
-0.39%
(-5.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4569...
Open
Â¥1,273
High
Â¥1,285
Low
Â¥1,266
Mkt. cap
75.89B
Avg. vol.
201.93K
Volume
215.50K
Dividend
4.50%
Quarterly dividend
Â¥14
Ex-dividend date
Mar 30, 2026
P/E ratio
21.09
52-wk high
Â¥1,725
52-wk low
Â¥1,266
EPS
Â¥60
Shares outstanding
63.52M
No. of employees
2K
Open
Â¥1,273
High
Â¥1,285
Low
Â¥1,266
Mkt. cap
75.89B
Avg. vol.
201.93K
Volume
215.50K
Dividend
4.50%
Quarterly dividend
Â¥14
Ex-dividend date
Mar 30, 2026
P/E ratio
21.09
52-wk high
Â¥1,725
52-wk low
Â¥1,266
EPS
Â¥60
Shares outstanding
63.52M
No. of employees
2K
News stories
From sources across the web
About Kyorin Pharmaceutical Co Ltd
CEO-
Employees2K
Founded1923
Headquarters-
SectorPharmaceutical industry
Websitekyorin-pharm.co.jp
Last report
May 12, 2026
Fiscal period
Q4 2026
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
33.80B / -
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
30.23B
28.50B
33.72B
33.80B
Cost of goods sold
16.97B
16.87B
19.09B
21.71B
Cost of revenue
16.97B
16.87B
19.09B
21.71B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.89B
12.64B
11.39B
13.13B
Operating expense
10.89B
12.69B
11.39B
13.13B
Total operating expenses
27.86B
29.56B
30.48B
34.84B
Operating income
2.37B
-1.06B
3.24B
-1.04B
Other non operating income
15.00M
11.00M
12.00M
13.00M
EBT including unusual items
2.73B
-699.00M
3.49B
-1.07B
EBT excluding unusual items
2.62B
-1.04B
3.51B
-1.07B
Income tax expense
628.00M
-93.00M
869.00M
-402.00M
Effective tax rate
23.02%
13.30%
24.87%
37.47%
Other operating expenses
-
-
-
-
Net income
2.10B
-606.00M
2.62B
-671.00M
Net profit margin
6.95%
-2.13%
7.78%
-1.99%
Earnings per share
-
-
-
-
Interest and investment income
233.00M
38.00M
235.00M
12.00M
Interest expense
-64.00M
-61.00M
-59.00M
-70.00M
Net interest expenses
169.00M
-23.00M
176.00M
-58.00M
Depreciation and amortization charges
2.00M
3.00M
3.00M
2.00M
EBITDA
3.52B
82.00M
4.39B
121.75M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer